Literature DB >> 8531585

Cyclosporin treatment of hyperimmunoglobulin E syndrome.

B Wolach, A Eliakim, A Pomeranz, A H Cohen, J Nusbacher, A Metzker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8531585     DOI： 10.1016/s0140-6736(96)91603-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.

Authors:  Ofir Wolach; Taco Kuijpers; Josef Ben-Ari; Ronit Gavrieli; Neta Feinstein-Goren; Marielle Alders; Ben Zion Garty; Baruch Wolach
Journal:  J Clin Immunol       Date:  2014-01-23       Impact factor: 8.317

2.  Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections.

Authors:  Baruch Wolach; Ronit Gavrieli; Dirk Roos; Sivan Berger-Achituv
Journal:  J Clin Immunol       Date:  2011-12-30       Impact factor: 8.317

3.  Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).

Authors:  Wen-I Lee; Jing-Long Huang; Shy-Jae Lin; Kuo-Wei Yeh; Li-Chen Chen; Meng-Ying Hsieh; Yhu-Chering Huang; Ho-Chang Kuo; Kunder D Yang; Hong-Ren Yu; Tang-Her Jaing; Chih-Hsun Yang
Journal:  J Clin Immunol       Date:  2010-12-01       Impact factor: 8.542

Review 4.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

Review 5.  Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.

Authors:  Hassan Hashemi; Masoumeh Mohebbi; Shiva Mehravaran; Mehdi Mazloumi; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.